View additional information about nRichDX participation at AMP 2025.
The emerging leader in liquid biopsy sample prep to present with Dr. Rena Xian of Johns Hopkins and showcase the Revolution Plus Instrument, kits, and data at conference booth #1029.
BOSTON, September 5, 2025 – nRichDX, best known for its Revolution Sample Prep System for liquid biopsy, will be introducing new products, presenting new data, and exhibiting at the Association for Molecular Pathology (AMP) Annual Meeting & Expo 2025.
Held November 13-15 at the Thomas M. Menino Convention & Exhibit Center in Boston, the conference is dedicated to exploring and recognizing the latest discoveries, research, and practices in molecular pathology.
nRichDX will exhibit in booth #1029, give a presentation from the AMP Innovation Spotlight Stage with Dr. Rena Xian, Associate Professor of Pathology at the Johns Hopkins Medical School, Director of the Division of Molecular Pathology, and Director of the JHU Molecular Diagnostics Lab.
nRichDX will also present three posters. Exhibits open at 11:15 AM on Thursday, November 13 and close at 1:30 PM on Saturday, November 15.
nRichDX at the AMP Annual Meeting & Expo
Products, presentations, posters, and live engagement.
Exhibit booth #1029
AMP Innovation Spotlight Stage presentation with Dr. Rena Xian of Johns Hopkins
Three scientific poster presentations
Revolution Plus™ Sample Prep System and the latest nRicher™ Cartridges on display
Explore the Latest Liquid Biopsy Sample Prep Solutions
AMP 2025 attendees considering liquid biopsy assays and the extraction of cfDNA, cfRNA, circulating cell-free total nucleic acid (cfTNA), or the enrichment of circulating tumor cells (CTCs), are encouraged to visit the nRichDX booth to see the latest liquid biopsy sample prep solutions.
Attendees can talk with liquid biopsy sample prep experts and investigate data on how extraction of higher yields of liquid biopsy analytes from samples can increase assay performance.
“nRichDX is setting the standard for liquid biopsy sample preparation performance, workflow, and flexibility with solutions engineered to easily deliver the highest yields of rare analytes from an unequaled range of liquid biopsy sample types and sample volumes.”
“nRichDX is proud to again support and participate in this year's AMP Annual Meeting & Expo in Boston,” Curtis said.
Revolution Plus™ and nRicher™ Cartridges
nRichDX will display the Revolution Plus™ Sample Prep System and the latest nRicher Cartridges.
The new nRicher Cartridges enable single extractions from the broadest sample input volume range of any commercially available kit, from 1 mL to 100 mL, without yield-lowering schemes used in other methods such as sample or eluate pooling, manual pre-extraction sample concentration, and sample transfer steps.
A recognized leader in providing high quality analyte yields from all sample input volumes, nRichDX significantly outperforms other methods in maximizing rare analyte yield from larger volume samples like urine, plasma, blood, and other biofluids.
Explore Revolution PlusAbout nRichDX
nRichDX® provides kits and automated solutions for isolating cfDNA, cfRNA, and CTCs. The patented Revolution Sample Prep System™ is engineered specifically for liquid biopsy applications and isolating analytes from blood, plasma, urine, and other biofluids.
It is the first and only high-yield, high-recovery, IVD-labeled sample prep platform to process from as little as 1 mL to 100 mL in a single extraction using the company's patented nRicher™ Cartridges.
Unlike other methods, Revolution sample prep doesn't require yield-lowering sample preconcentration, eluate pooling, sample transfer, or sample re-elution steps.
nRichDX helps solve one of precision medicine's greatest problems: inaccurate or incomplete diagnostic results for liquid biopsy-based applications due to insufficient analyte.
Learn more about nRichDX